All Pharma News
price-trendAsk Us
Rivus Pharma Announces Completion of Enrollment in Phase 2a HuMAIN Trial of HU6

Rivus Pharma Announces Completion of Enrollment in Phase 2a HuMAIN Trial of HU6
PR NEWSWIRE
05 Jan 2024
Share Share
Rivus Announces Expansion of HU6 Clinical Program and Leadership Appointments

Rivus Announces Expansion of HU6 Clinical Program and Leadership Appointments
PR NEWSWIRE
15 Nov 2023
Share Share
Phase 2a of HU6, Rivus` Controlled Metabolic Accelerator, Demonstrates Benefit

Phase 2a of HU6, Rivus` Controlled Metabolic Accelerator, Demonstrates Benefit
PR NEWSWIRE
05 Oct 2023
Share Share
Rivus to Present Results from a Phase 2a Trial Evaluating HU6

Rivus to Present Results from a Phase 2a Trial Evaluating HU6
PRNEWSWIRE
04 Nov 2022
Share Share
Rivus raises $132m to advance clinical development of obesity treatment

Rivus raises $132m to advance clinical development of obesity treatment
PHARMACEUTICAL-TECHNOLOGY
23 Sep 2022
Share Share
Rivus raises $132M series B as metabolic pipeline heats up

Rivus raises $132M series B as metabolic pipeline heats up
Gabrielle Masson FIERCEBIOTECH
22 Sep 2022
Share Share
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6
PRNEWSWIRE
22 Sep 2022
Share Share
Rivus throws down liver fat data on quest to climb NASH mountain

Rivus throws down liver fat data on quest to climb NASH mountain
A. Armstrong FIERCEBIOTECH
10 Feb 2022
Share Share
Rivus Pharma shows +ve results from phase 1 trial of HU6

Rivus Pharma shows +ve results from phase 1 trial of HU6
PHARMABIZ
02 Nov 2021
Share Share
Rivus Pharmaceuticals Announces Positive Results from Phase 1 Trial

Rivus Pharmaceuticals Announces Positive Results from Phase 1 Trial
PRNEWSWIRE
01 Nov 2021
Share Share